63 results
DFAN14A
SLGCW
SomaLogic, Inc.
26 Dec 23
Additional proxy materials by non-management
5:03pm
overlooked and/or ignored by the Transaction Committee. In the meantime, Madryn is conducting its own investigation to identify who else the Transaction
DFAN14A
SLGCW
SomaLogic, Inc.
21 Dec 23
Additional proxy materials by non-management
9:26am
and, as to all other matters, upon information and belief, including the investigation of undersigned counsel, the review of books and records produced
425
EX-2.1
SLGCW
SomaLogic, Inc.
4 Oct 23
Business combination disclosure
8:14am
, an internal investigation of any officer, manager, or supervisor of the Company or any of its Subsidiaries with respect to any claims with respect … a Governmental Entity or other Person has conducted or has been ordered to conduct a remedial investigation, removal or other response actions pursuant
8-K
EX-2.1
SLGCW
SomaLogic, Inc.
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:11am
, an internal investigation of any officer, manager, or supervisor of the Company or any of its Subsidiaries with respect to any claims with respect … a Governmental Entity or other Person has conducted or has been ordered to conduct a remedial investigation, removal or other response actions pursuant
S-3
EX-5.1
vz5ftu8cs 178b
28 Oct 22
Shelf registration
7:09pm
424B3
imsc9do aj8z1bde
24 Oct 22
Prospectus supplement
5:13pm
S-8
EX-5.1
mau47b4
23 Sep 22
Registration of securities for employees
5:37pm
POS AM
xf5fa a7w9coek1
23 Sep 22
Prospectus update (post-effective amendment)
5:23pm
8-K
EX-2.1
kgtbl1 ozlsnd5o4
27 Jul 22
SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
6:08am
POS AM
EX-5.1
aaxt3hon gs0t
22 Jul 22
Prospectus update (post-effective amendment)
5:26pm
POS AM
ws3ulayvv
22 Jul 22
Prospectus update (post-effective amendment)
5:26pm
8-K
EX-99.1
lmzoj
12 May 22
SomaLogic Reports First Quarter 2022 Financial Results
4:14pm
424B3
4f68g3h
11 May 22
Prospectus supplement
5:04pm
10-K
EX-10.36
c25jbp
29 Mar 22
Annual report
4:34pm
10-K
EX-10.34
mbujgy0g
29 Mar 22
Annual report
4:34pm
10-K
xeed grkn4vl7y
29 Mar 22
Annual report
4:34pm
8-K
EX-99.1
qzzqm8q6p3
29 Mar 22
SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results
4:15pm
8-K
EX-10.1
eazgz841 iq
16 Feb 22
Entry into a Material Definitive Agreement
4:30pm